15.11.2014 Views

Vol 44 # 4 December 2012 - Kma.org.kw

Vol 44 # 4 December 2012 - Kma.org.kw

Vol 44 # 4 December 2012 - Kma.org.kw

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>December</strong> <strong>2012</strong><br />

KUWAIT MEDICAL JOURNAL 306<br />

Fig. 3: MRI of the patient with brain abscess, showing pre (3a) and<br />

post-radiosurgery imaging (3b)<br />

and were referred for chemotherapy and radiation<br />

therapy. The patient with brain metastasis was further<br />

investigated and his origin of the primary disease was<br />

found to be in the lungs. The patient was referred to<br />

radiation oncologist for further management.<br />

Stereotactic drainage of the intracranial abscess<br />

was performed in five patients. Pus was sent for<br />

culture sensitivity and postoperatively, patients<br />

were managed conservatively with antibiotics.<br />

Post surgical imaging showed reduction in size of<br />

the abscess cavities and clinically all the patients<br />

improved.<br />

Post-operative complication occurred in one<br />

patient. This was asymptomatic hemorrhage after<br />

tissue biopsy which was managed conservatively.<br />

There was no other procedure-related morbidity or<br />

mortality.<br />

DISCUSSION<br />

Stereotactic surgery has been recognized since<br />

many decades after the use of freehand biopsy<br />

techniques resulted in too many postoperative<br />

complications [14-16] .<br />

Stereotactic surgery either for diagnosis or<br />

treatment provides us precision, accuracy and safety<br />

to localize the target in the brain. Stereotactic biopsy<br />

stresses the importance of histological diagnosis<br />

with low morbidity and zero mortality. Many reports<br />

are published in the literature on the safe use of this<br />

technique and a tissue diagnosis is always required<br />

prior to treatment for most cerebral lesions. In their<br />

early experience, Lunsford et al [17] published results of<br />

102 patients with brain disorders who were referred<br />

to University of Pittsburgh for surgical exploration,<br />

using CT-guided stereotactic system. All the patients<br />

were referred because of critical size and location of<br />

the lesions in brain. Diagnostic stereotactic biopsy<br />

demonstrated diagnosis in 98 (96.1%) patients.<br />

Direct therapeutic intervention using this technique<br />

was possible in 26 (25.5%) patients. There was no<br />

morbidity and mortality seen in this early series.<br />

According to them, histological diagnosis must be<br />

sought in all patients with symptomatic brain lesions<br />

regardless of their size or location and “Empiric”<br />

forms of therapy are no longer justified in the age<br />

of CT scanning. Lunsford et al[ 18] reported another<br />

series of 39 patients with craniopharyngiomas who<br />

underwent multimodality stereotactic techniques.<br />

Cystic craniopharyngiomas were treated successfully<br />

with stereotactic implantation of radioactive P32 in<br />

the cystic cavity of the tumor. The success rate was<br />

96%. Kondziolka et al [9] reported a series of 29 patients<br />

with brain abscess. Out of these, 22 (76%) patients had<br />

stereotactic abscess drainage with purulent centers<br />

and seven (24%) patients underwent lesion biopsy<br />

for diagnosis. Twelve patients with large abscesses of<br />

diameter > 3 cm, underwent stereotactic insertion of<br />

drainage catheters. Long-term clinical and imaging<br />

follow-up confirmed disease resolution in 21 patients<br />

(72%) and eventual abscess resolution occurred<br />

in an additional six patients (21%), who required<br />

multiple procedures. Lakecivic et al [19] published an<br />

article to differentiate the results of survival and<br />

outcome of patients with malignant brain gliomas<br />

who were treated by different modes. The control<br />

group of 21 patients had undergone craniotomy and<br />

surgical excision, followed by oncological protocol<br />

while the case group of 11 patients underwent<br />

stereotactic biopsy followed by oncological protocol.<br />

The majority of patients diagnosed by a stereotactic<br />

biopsy survived for more than two years. The<br />

survival and outcome for the patients in whom a<br />

stereotactic biopsy was performed were notably<br />

better compared to the patients who were diagnosed<br />

after surgical excision. Consequently, it appears<br />

that a stereotactic biopsy is a better option for<br />

primary treatment of patients with malignant brain<br />

gliomas when the survival and quality of life are<br />

concerned. Broggi et al [20] published their experience<br />

in 35 patients who underwent stereotactic biopsy<br />

for deeply located lesions. According to them, the<br />

biopsies confirmed the diagnosis based on clinical<br />

and imaging findings in 25 patients but in 10 patients<br />

the histological diagnosis was different from the<br />

presumptive one. The treatment option was changed<br />

in these ten patients. Ostertag et al [4] reported their<br />

experience with 302 cases of stereotactic biopsy and<br />

advocated that exploratory craniotomies, risky freehand<br />

punctures and aspirations deep in the brain<br />

should not be done without prior diagnosis.<br />

Our report emphasises the importance of<br />

histological diagnosis to avoid the hazards of<br />

treatments based on clinical and radiological<br />

findings. Only one of 40 patients had complication,<br />

which shows safety profile of frame based stereotactic<br />

surgery.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!